Aidea Pharma: Termination of the framework contract for the cooperative development of new drug projects with Pharmaron

Aidea Pharma announced that due to significant changes in the project's objective environment and market prospects, the company and Nanjing Yaoshi Technology Co., Ltd. have mutually agreed to terminate the project cooperation development framework contract and the associated service contract ahead of schedule. This termination agreement will not have a significant impact on the company's operating performance for the year 2024 and will not affect the company's financial condition for 2025 and beyond. Aidea Pharma will continue to focus on the core development areas of anti-HIV drugs and human protein products, promoting steady growth in its main business